Literature DB >> 4083869

Antimicrobial susceptibility of Corynebacterium group D2.

M Santamaría, C Ponte, I Wilhelmi, F Soriano.   

Abstract

The in vitro susceptibility of 30 Corynebacterium group D2 strains to nine antimicrobial agents was determined. Vancomycin and norfloxacin were the most active agents tested. All strains were resistant to ampicillin and cephalothin, all except one were resistant to gentamicin, and the activity of erythromycin, novobiocin, tetracycline, and rifampin varied.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4083869      PMCID： PMC180344          DOI： 10.1128/AAC.28.6.845

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens.

Authors:  P S Riley; D G Hollis; G B Utter; R E Weaver; C N Baker
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

2.  "Diphtheroid" pneumonia.

Authors:  N F Jacobs; C A Perlino
Journal:  South Med J       Date:  1979-04       Impact factor: 0.954

3.  Rapid identification of antibiotic-resistant corynebacteria with the API 20S system.

Authors:  M C Kelly; I D Smith; R J Anstey; J H Thornley; R P Rennie
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

4.  Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms.

Authors:  F Soriano; C Ponte; M Santamaria; J M Aguado; I Wilhelmi; R Vela; L C Delatte
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

5.  The emergence of coryneform bacteria as a cause of nosocomial infections in compromised hosts.

Authors:  V M Young; W F Meyers; M R Moody; S C Schimpff
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965
  5 in total
  17 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin.

Authors:  F Soriano; R Fernández-Roblas; J Zapardiel; J L Rodríguez-Tudela; P Avilés; M Romero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

3.  In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

Authors:  A Philippon; F Bimet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

4.  In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

Authors:  J A García-Rodriguez; J E García Sánchez; J L Muñoz Bellido; T Nebreda Mayoral; E García Sánchez; I García García
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients.

Authors:  F Soriano; J L Rodriguez-Tudela; R Fernández-Roblas; J M Aguado; M Santamaría
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Emergence of urea-splitting multi-resistant coryneform bacteria (Corynebacterium group D2) as pathogens.

Authors:  F Soriano
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

7.  Isolation of Corynebacterium group D2 from clinical specimens.

Authors:  B Van Bosterhaut; G Claeys; J Gigi; G Wauters
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

8.  Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.

Authors:  R Fernández-Roblas; S Prieto; M Santamaría; C Ponte; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

9.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Urinary tract infection with Corynebacterium urealyticum in South Africa.

Authors:  D Walkden; K P Klugman; S Vally; P Naidoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.